Overview of recent strategic advances in medicinal chemistry

G Wu, T Zhao, D Kang, J Zhang, Y Song… - Journal of medicinal …, 2019 - ACS Publications
Introducing novel strategies, concepts, and technologies that speed up drug discovery and
the drug development cycle is of great importance both in the highly competitive …

Targeting the HGF/Met signaling pathway in cancer therapy

F Cecchi, DC Rabe, DP Bottaro - Expert opinion on therapeutic …, 2012 - Taylor & Francis
Introduction: Under normal conditions, hepatocyte growth factor (HGF)-induced activation of
its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …

Software and resources for computational medicinal chemistry

C Liao, M Sitzmann, A Pugliese… - Future medicinal …, 2011 - Taylor & Francis
Computer-aided drug design plays a vital role in drug discovery and development and has
become an indispensable tool in the pharmaceutical industry. Computational medicinal …

Hierarchical virtual screening approaches in small molecule drug discovery

A Kumar, KYJ Zhang - Methods, 2015 - Elsevier
Virtual screening has played a significant role in the discovery of small molecule inhibitors of
therapeutic targets in last two decades. Various ligand and structure-based virtual screening …

Measuring and interpreting the selectivity of protein kinase inhibitors

LA Smyth, I Collins - Journal of chemical biology, 2009 - Springer
Protein kinase inhibitors are a well-established class of clinically useful drugs, particularly
for the treatment of cancer. Achieving inhibitor selectivity for particular protein kinases often …

(−)-Oleocanthal as a c-Met inhibitor for the control of metastatic breast and prostate cancers

AY Elnagar, PW Sylvester, KA El Sayed - Planta medica, 2011 - thieme-connect.com
The proto-oncogene receptor tyrosine kinase c-Met encodes the high-affinity receptor for
hepatocyte growth factor (HGF). Dysregulation of the HGF‐c-Met pathway plays a significant …

Computational approaches for protein function prediction: a combined strategy from multiple sequence alignment to molecular docking-based virtual screening

CL Pierri, G Parisi, V Porcelli - … et Biophysica Acta (BBA)-Proteins and …, 2010 - Elsevier
The functional characterization of proteins represents a daily challenge for biochemical,
medical and computational sciences. Although finally proved on the bench, the function of a …

Synthesis and c-Met kinase inhibition of 3, 5-disubstituted and 3, 5, 7-trisubstituted quinolines: identification of 3-(4-acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7 …

Y Wang, J Ai, Y Wang, Y Chen, L Wang… - Journal of medicinal …, 2011 - ACS Publications
By use of an improved synthetic strategy, a series of 3, 5-disubstituted and 3, 5, 7-
trisubstituted quinolines were readily prepared. 3, 5, 7-Trisubstituted quinolines 21a− c, 21l …

MET Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma

X Lu, N Peled, J Greer, W Wu, P Choi, AH Berger… - Cancer research, 2017 - AACR
Targeting somatically activated oncogenes has revolutionized the treatment of non–small
cell lung cancer (NSCLC). Mutations in the gene mesenchymal–epithelial transition (MET) …

Discovery andw biological evaluation of novel 6, 7-disubstituted-4-(2-fluorophenoxy) quinoline derivatives possessing 1, 2, 3-triazole-4-carboxamide moiety as c-Met …

S Zhou, H Liao, M Liu, G Feng, B Fu, R Li… - Bioorganic & Medicinal …, 2014 - Elsevier
Abstract A series of 6, 7-disubstituted-4-(2-fluorophenoxy) quinoline derivatives possessing
1, 2, 3-triazole-4-carboxamide moiety were designed, synthesized and evaluated for their in …